US Stock MarketDetailed Quotes

ADIL Adial Pharmaceuticals

Watchlist
  • 0.7412
  • -0.0468-5.94%
Close Feb 14 16:00 ET
  • 0.7410
  • -0.0002-0.03%
Post 20:01 ET
4.80MMarket Cap-0.22P/E (TTM)

About Adial Pharmaceuticals Company

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.

Company Profile

SymbolADIL
Company NameAdial Pharmaceuticals
Listing DateJul 27, 2018
Founded2010
CEOMr. Cary J Claiborne
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address4870 Sadler Road,Suite 300
CityGlen Allen
ProvinceVirginia
CountryUnited States of America
Zip Code23060
Phone1-434-487-8196
Websitehttp://www.adialpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Cary J Claiborne
  • Director, President and Chief Executive Officer
  • 801.62K
  • Tony Goodman
  • Director and Chief Operating Officer
  • 261.93K
  • Vinay Shah
  • Chief Financial Officer
  • --
  • Kevin Schuyler, C.F.A.,M.B.A.
  • Chairman of the Board and Lead Independent Director
  • 60.22K
  • James W. Newman, Jr
  • Independent Director
  • 56.22K
  • J. Kermit Anderson
  • Independent Director
  • 59.22K
  • Robertson H. Gilliland, M.B.A.
  • Independent Director
  • 53.22K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025